drugset / Trial / NCT00740207

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

NCT00740207

Phase 4 Completed 33 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupTriple-blindDiagnostic

Summary

The purpose of this study is to compare ISOVUE-250 and VISIPAQUE 270 for motion artifact and pain following intraarterial injection for peripheral DSA.

Timeline

Start
2008-09
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent Other
Comparator Iopamidol Diagnostic / imaging agent Other